Armata Pharmaceuticals, Inc. Common Stock (ARMP)
EBITDA Growth
-1485.37%
TTM · Period ending:
ARMP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-1485.37%period ending
Latest reported-1485.37%period ending
ARMP TTM EBITDA YoY % (-23.08% → -1485.37%)
Year-over-year change
High-resolution chart · PNG
ARMP ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -15.534% | |
| -10.8911% | |
| -29.7872% | |
| -14.8936% | |
| -13.1868% | |
| -57.8125% | |
| 3.0928% | |
| -27.027% | |
| -75% | |
| -23.0769% |